Disease/Infection News

RSS

Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Researchers investigate the clinical efficacy of semaglutide in controlling urine albumin-to-creatinine ratio in overweight patients with chronic kidney disease.

31 Oct 2024

WHO expands Emergency Use Listing for mpox diagnostics

As part of ongoing efforts to enhance quality-assured testing options, the World Health Organization (WHO) has listed two additional mpox in vitro diagnostics under its Emergency Use Listing (EUL) procedure.

30 Oct 2024

Long-term air pollution exposure increases asthma risk in children and adults

Researchers review existing evidence on the effects of long-term exposure to air pollution in the form of fine particulate matter on the risk of developing asthma.

30 Oct 2024

New toolkit aims to help U.S. hospitals spot deadly viral hemorrhagic fevers faster and safer

Researchers develop a laboratory toolkit to assist frontline healthcare facilities or the care of patients with suspected viral hemorrhagic fevers.

30 Oct 2024

Researchers uncover link between smell and inflammation

Researchers from the Charlie Dunlop School of Biological Sciences, in collaboration with The Oxford Research Centre in the Humanities, reveal a powerful link between olfactory loss and inflammation in a staggering 139 medical conditions. This research – led by professor emeritus Michael Leon, and researchers Cynthia Woo and Emily Troscianko – emphasizes a little-known but potentially life-altering connection: the role our sense of smell plays in maintaining our physical and mental health.

30 Oct 2024

New funding boosts efforts to revitalize flint communities

The Prevention Research Center of Michigan has spent decades researching ways to create safer, more inviting, and accessible neighborhood spaces to improve physical and mental health. Now, $5 million in renewed funding from the U.S. Centers for Disease Control and Prevention will enable the center to continue its community-based participatory research projects through at least 2029.

30 Oct 2024

New test promises to end malaria

Almost half of the world's population is at risk of malaria infection, with children and pregnant women at the highest risk of getting sick and dying from the disease. Current methods to detect this potentially deadly infection rely on obtaining an invasive blood sample, and each test has significant limitations that restrict its utility.

29 Oct 2024

New initiative activated to strengthen response to mpox public health crisis

In October 2024, WHO and partners, in collaboration with Member States, activated the Global Health Emergency Corps (GHEC) for the first time to provide support to countries facing mpox outbreaks.

29 Oct 2024

WHO reports alarming rise in tuberculosis cases in 2023

The World Health Organization (WHO) today published a new report on tuberculosis revealing that approximately 8.2 million people were newly diagnosed with TB in 2023 – the highest number recorded since WHO began global TB monitoring in 1995.

29 Oct 2024

Unraveling the mechanism of Shufeng Jiedu Capsules in influenza treatment

Shufeng Jiedu Capsules (SFJD), a traditional Chinese medicine preparation, are widely used in the clinical treatment of influenza, yet their mechanism of action remains unclear.

29 Oct 2024

Machine learning reveals distinct clinical states in pneumonia patients

Two patients being treated for pneumonia, an infection that causes difficulty breathing due to fluid-filled sacs in the lungs, can look vastly different and have opposing outcomes. Yet doctors struggle to accurately predict patients' prognoses and determine the most effective treatments.

29 Oct 2024

African production of mpox vaccines could secure the continent’s health

As Africa grapples with multiple outbreaks of mpox, public health leaders say locally produced vaccines are vital to end donation dependence and secure the continent's health.

29 Oct 2024

One in four healthy young Marines report long-term physical, cognitive, or psychiatric effects after mild COVID-19

Researchers examine the long-term health effects of SARS-CoV-2 infection in a cohort of United States Marines.

29 Oct 2024

Study identifies six cancer susceptibility genes

Identification of six cancer susceptibility genes offers new insights into genetic risk factors, potentially enhancing early detection and treatment strategies.

29 Oct 2024

A promising new strategy for malaria drug development

Malaria kills over 600,000 people a year, and as the climate warms, the potential range of the disease is growing. While some drugs can effectively prevent and treat malaria, resistance to those drugs is also on the rise.

29 Oct 2024

Scientists discover novel compound to combat age-related blindness

Rensselaer Polytechnic Institute's Christopher Cioffi, Ph.D., Thomas and Constance D'Ambra Professor in Organic Chemistry, has been collaborating with Konstantin Petrukhin, Ph.D., Professor of Ophthalmic Science at Colombia University, to develop compounds to treat dry age-related macular degeneration (AMD) and Stargardt disease - both blindness-causing diseases.

28 Oct 2024

Research identifies respiratory transmission potential of H5N1 virus

A highly pathogenic avian influenza (HPAI) H5N1 virus, isolated from the eye of a farm worker who became infected through contact with dairy cows, was lethal in mice and ferrets infected in a high-containment laboratory environment, according to a new study in Nature.

28 Oct 2024